The Price of a Good Life: Singapore’s Longevity is Outrunning Its Own Preparedness

Singaporeans now live to 83.5 years on average, a preliminary 2024 figure up 0.9 years over the past decade, placing the country among the world’s six recognised Blue Zones.  Males reach 81.2 years, females 85.6 years, and life expectancy at age 65 has climbed to 21.2 years.  This is a public health achievement, built on decades of improving healthcare access and chronic disease management.  It is also, quietly, the single largest unfunded liability most Singaporean households will ever carry, and almost nobody prices it correctly.

The World Health Organisation declared in 2015 that the rise in chronic conditions among older adults constitutes a worldwide epidemic, one that healthcare financing systems in both high-income and low-to-middle-income regions will be forced to absorb over coming decades.  The WHO distinguishes life expectancy and healthy life expectancy, HALE, “the average number of years that a person can expect to live in full health.”  OECD analysis, aligned with WHO data, found the gap between life expectancy and healthy life expectancy at age 60 stood at 5.7 years in 2021, itself up from 5.2 years in 2000.  Extra years of life are not, on average, extra years of health.  They are, increasingly, extra years spent managing exactly the illnesses this document catalogues.

The Illness Bill Nobody Budgets For

Cancer alone produced 29,200 new cases in Singapore in 2023, an age-standardised incidence rate of 284 per 100,000.  Ischaemic heart disease drove roughly 8,500 hospital admissions and accounted for 19.7% of all deaths.  Stroke produced a further 7,200 admissions and 5.6% of deaths.  Cancer and heart-surgery bills run S$50,000 to S$120,000 before accounting for six or more months of lost income, which is why the recommended critical illness cover sits at S$250,000 to S$350,000.

The Life Insurance Association of Singapore’s 2022 Protection Gap Study found this recommendation and reality sit nowhere near each other.  Progress, yes.  Adequacy, no.  The average critical illness coverage needed for an economically productive adult sits at S$316,603.  Average existing coverage sits at just S$59,776, a shortfall of S$264,586 per person, and a national aggregate critical illness protection gap of S$579 billion.  The mortality protection gap adds a further S$373 billion.  The LIA’s own report is explicit about why this matters now: it cites “extended life expectancy” directly as a driver of the urgency; the same longevity Singapore celebrates as a Blue Zone achievement is the reason the funding gap keeps compounding rather than closing.

26.2% of Singapore residents already carry two or more chronic conditions, and that prevalence rises to between 50% and 98% among residents aged 65 and above.  The common combinations – hypertension with lipid disorders, chronic kidney disease with hypertension, diabetes with ischaemic heart disease – are not rare edge cases.  They are the median outcome for an ageing resident.  Multimorbidity drives more than double the total healthcare expenditure of a single-disease case, and chronic disease management alone can run S$750,000 or more annually for the most complex cases.  A single-claim critical illness policy was never built for a population where one in four residents will eventually stack diagnoses rather than face one in isolation, and a policyholder purchasing coverage for “a critical illness” in the singular has already misunderstood the actuarial reality he is insuring against.

Medical Inflation is Outrunning Every Financial Plan Built Before It

Medical costs in Singapore rose 13.7% in 2023, moderated only slightly to 12% in 2024, and insurers project the rate will hold at roughly 12% through 2025, just under the Asia-Pacific average of 12.3%.  General inflation over the same period has run at 3% to 4%.  A financial plan calculated once, at the point of policy purchase, and left untouched thereafter is not a conservative plan.  It is already obsolete by the time the policyholder reaches the age the plan was built to protect, because the cost of the care it was meant to fund has compounded at three to four times the rate the plan itself assumed.

The Retirement Shortfall, by the Numbers

A comfortable retirement over 20 to 30 years requires a nest egg of S$1.0 million to S$1.3 million, using the standard 4% withdrawal rule against average annual spending.  Retiree households currently spend roughly S$1,940 a month, a figure that implies a considerably smaller minimum nest egg of S$480,000 to S$584,000, still above what most current retirees have accumulated.  Only 50% of active CPF members turning 55 in 2022 managed to set aside the Full Retirement Sum in cash, up from 40% in 2018, and 30% of that same cohort could not meet even the Basic Retirement Sum through any combination of cash and property.  25% of Singaporeans have not started retirement planning at all.  Only 35% across every age group report having a formal retirement plan in place, despite 63% naming retirement savings their top personal finance priority.  Intention and execution are almost entirely disconnected in this dataset, and the gap between the two widens every year medical inflation runs ahead of wage growth.

74% of Singaporeans own three or more insurance products, and 38% now say they prioritise insurance within their retirement planning.  Yet only 28% hold a standalone critical illness plan, with the majority instead relying on thin riders bolted onto a life policy, never sized for the S$316,603 the LIA’s own research says an economically productive adult needs.  A separate Sun Life survey found 42% of respondents plan to defer retirement-expense planning until five years or less before retirement, and 15% of even high-income earners had not saved at least 10% of their income toward retirement at all.

The Verdict

Living to 83.5 was never the difficult part of this equation.  Funding the last two decades of it, against 12% medical inflation, a 26.2% multimorbidity rate, and a critical illness protection rate sitting at just 28% of the population, is where most Singaporean households are quietly failing an exam most of them have not yet realised has already started.  The World Health Organisation named the epidemic in 2015.  LIA Singapore has now quantified the exact shortfall in dollars.  The only variable left unresolved is whether households act on the number before the diagnosis arrives, or after.

---

Terence Nunis | Executive Chairman, Equinox Zenith | Author, The 1% Playbook: The Billionaire Cheat Code

Insurers’ CI Portfolios are Under Pressure

For an insurer’s critical illness portfolio to be viable, it has to be backed by assets.  These assets are invested out to diversify that risk, and create an income stream to cover the cost of claims.  Because of medical inflation, and the rising claims, premiums have not kept pace with payouts for insurers.  Some of them have portfolios with negative returns.  Despite this, Singapore’s robust regulatory framework ensures that there is little to no chance of insurer default.  Even if that were to happen, there is a mechanism to address the needs of claimants. 

What this does mean is that premiums are expected to rise.  Most critical illness policies do not guarantee level riders, so there is a mechanism for insurers to manage costs.  We are seeing new products on the market which are more targetted, and with higher entry premiums.  Due to the ageing population, insurance is a need.  The average Singaporean will live long enough to get a critical illness.

A Closer Look at Critical Illness: The Coverage Gap, the Court Cases, & Why One Policy is Never Enough

Critical illness plans are a foundation for building anybody’s portfolio of insurance policies.  In Singapore, it is almost guaranteed that the average person will live long enough to eventually get a critical illness, most likely some form of cancer.  Death is a one-time cost.  Critical illnesses are more insidious and may cost a family two sources of income: the one who is sick, and the one who has to look after him.

The Underinsurance, Measured Properly

The Life Insurance Association of Singapore’s 2022 Protection Gap Study found the average working adult carries a critical illness protection gap of 74%, amounting to S$579 billion in unfunded need nationally.  A more granular figure from the same body puts the average coverage needed for an economically productive adult at S$316,603, against average existing coverage of just S$59,776, a shortfall of S$264,586 per person.  A separate 2023 study found over 68% of Gen Z respondents held no critical illness coverage at all.  Platform workers, private-hire drivers and delivery riders carry a 91% gap against the national average, the demographic least equipped to absorb a lost income shock in the first place.

The Cost of a Critical Illness

Late-stage cancer treatment alone runs S$100,000 to S$200,000 annually in Singapore.  Cancer accounts for 26.2% of all deaths nationally and 73.17% of all critical illness claims.  Chemotherapy alone can run from roughly S$1,500 per cycle, with a full treatment course extending across many cycles over months.  Against that, the average actual critical illness claim payout in Singapore sits at just S$52,343.  The Life Insurance Association recommends coverage equal to 3.9 times annual income, calculated to sustain a typical five-year recovery period, which LIA’s own research confirms is roughly how long it takes a household to recover financially from a critical illness event without adequate insurance backing it.

A single-pay critical illness policy pays out once and terminates.  Cancer, the illness driving nearly three-quarters of all claims, does not respect that structure.  Recurrence, a second unrelated cancer diagnosis years later, or progression from early to intermediate to late stage are all clinically distinct events a single-payout policy was never built to handle.  Manulife’s Critical Illness Income Protection plan offers total cancer-related payouts of up to 900% of the sum insured.  AIA’s comparable multi-stage product reaches 600%, while its newer AIA Absolute Critical Cover allows claims up to 500% of the coverage amount with a full restoration of coverage 12 months after the last claim, plus double payout if the identical illness recurs.  Prudential’s comparable structure tops out at 300%.  Every one of these products imposes a waiting period between claims, commonly 12 months for a different condition and 24 months for relapse of the same condition.

The Recent Prudential Case, and Why the Denial is Controversial

A 45-year-old stroke survivor is currently suing Prudential Assurance Company Singapore in the State Courts, seeking S$108,500 in critical illness payouts after undergoing emergency brain aneurysm surgery in 2023.  The controversy sits in the surgical method, not the diagnosis.  Prudential’s policy defines claimable brain aneurysm surgery narrowly as a surgical craniotomy, an open-skull procedure, and excludes endovascular repair, the minimally invasive alternative her treating doctors performed.  The claimant states she was never offered craniotomy as an alternative.  Her treating team made the surgical decision based on clinical judgement, presumably because endovascular repair carried a better risk profile for her specific presentation, and that clinical decision then became the reason her claim failed.  Prudential rejected the argument that this made it a market outlier, stating other Singapore insurers structure their coverage the same way, a defence that is legally sound but does nothing to address the underlying unfairness: a policy exclusion triggered by a doctor’s treatment choice, made without the patient’s knowledge that the choice carried a financial consequence, is a definition trap dressed up as a coverage boundary.  A related case makes the insurer-specific nature of this trap starkly visible.  A 43-year-old woman who suffered five brain aneurysms had her claim rejected by Prudential on the identical craniotomy-versus-endovascular distinction, while AIA approved a comparable claim under a separate policy she held.  Two insurers, two outcomes, one identical medical event, decided entirely by which company’s contract happened to be in force.

AIA Singapore has disclosed paying out more than S$40 billion in death, critical illness, accident, hospitalisation, and maturity proceeds over the past decade, and its current flagship products carry wide coverage: AIA Absolute Critical Cover spans 187 medical conditions including 150 multi-stage critical illnesses, and AIA Ultimate Critical Cover offers the market’s first unlimited reset benefit.  The Prudential-versus-AIA brain aneurysm case above shows why that gap matters: two insurers reached opposite conclusions on comparable claims.

In another case, Singapore’s High Court, in a ruling by Senior Judge Tan Siong Thye, held that a critical illness payout exceeding S$450,000, received by a woman who suffered two strokes in 2017 and 2020, was not a divisible matrimonial asset in her subsequent divorce.  Her husband argued the payout should be shared since he was the family’s primary income earner and had indirectly funded the premiums.  The court rejected this, finding no evidence he had contributed to the premiums, and ruling the funds were intended for her recovery and long-term care rather than as an investment gain.  A well-structured critical illness policy, in this instance, did the job it was purchased to do.

The Verdict

Every dispute in this piece turns on the same variable: the exact wording of a policy definition, read and understood before the claim event, not after it, combined with an industry structure that gives Singapore consumers no independently verifiable way to compare insurers on actual claims outcomes.  A protection gap of S$264,586 per adult, an average payout barely a tenth of what a single year of late-stage treatment can cost, and a market with no published settlement ratio to guide the choice between insurers, together make a compelling case for holding more than one policy.

---

Terence Nunis | Executive Chairman, Equinox Zenith | Author, The 1% Playbook: The Billionaire Cheat Code

Critical Illness Spotlight: Diabetes

Even when you are young, there is still a need for hospitalisation and critical illness insurance plans.  One reason, for Singaporeans, is diabetes.  According to a Channel NewsAsia report, dated the 16^th March 2015, Singapore’s diabetes patients are amongst the youngest in Asia.

The report said, and I quote, “A local study on patients with Type 2 diabetes across nine Asian territories showed that Singapore has the highest proportion of younger patients.  The study among 319 patients was conducted by the Asian Diabetes Foundation from 2012 to 2014, and included patients from Singapore, Thailand, China, the Philippines, Hong Kong, India, South Korea, Taiwan, Thailand and Vietnam.  The study found that three in 10 patients in Singapore had diabetes before turning 40.  Younger patients also fared poorly in terms of glucose control, hypertension and cholesterol management compared to older patients.”

According to statistics, almost 500,000 Singaporeans have Type 2 diabetes.  Diabetes mellitus Type 2, the most common form of diabetes, is a metabolic disorder with effects that get progressively worse over the long term.  It is characterised by high blood sugar, insulin resistance, and the relative lack of insulin.  The most common symptoms are increased thirst, frequent urination, and unexplained weight loss.  They may also include increased hunger, lethargy, and sores that do not heal.  Often symptoms come on slowly.  In the long-term, there will be complications such as high blood sugar, heart disease, strokes, diabetic retinopathy which may result in blindness, kidney failure, and poor blood flow to the limbs which may eventually necessitate amputations.

Type 2 diabetes is primarily due to obesity and a lack enough exercise in people who are genetically predisposed.  This lack of exercise and increased obesity is increasing amongst Singaporeans.  Whilst treatment is possible through lifestyle changes, and medication, you must still deal with the possible long-term consequence.  And that means future possible treatment.

According to the Straits Times report, published on the 12^th February 2015, more people here and around the world are succumbing to diabetes.  Worldwide, it is expected to affect 66 million people, which is more than double the 171 million in 2000.  This is according to the World Health Organisation.

There are critical illness plans that specifically cover complications from diabetes and there are provisions in plans that do not specifically mention diabetes but cover its complications as part of the plan, all this providing that none of them are a pre-existing condition.  So a critical illness plan will cover heart disease, liver failure and stroke even if the plan itself does not mention diabetes.  Like any sort of plan, it is generally advisable to take the up when you are young and healthy.  Should complications develop, you want to be thinking of treatment, not how to pay for them.